Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

Overview of attention for article published in Journal of Pain Research, August 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

法司努单抗（INN：Fasinumab）是一种人单克隆抗体，设计用于治疗急性坐骨神经痛. 该药物由梯瓦制药工业有限公司和再生元制药公司合作开发. 目前正处于III期试验（NCT03245008、NCT02683239和NCT03161093）.

Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain.